REQUEST A DEMO
Total
USD $0.00
Search more companies

Samsung Pharmaceutical Co.,Ltd. (South Korea)

Main Activities: Pesticide, Fertilizer, and Other Agricultural Chemical Manufacturing | Pharmaceutical and Medicine Manufacturing
Full name: Samsung Pharmaceutical Co.,Ltd. Profile Updated: August 24, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Samsung Pharmaceutical Co.,Ltd. is engaged in manufacturing, supply and distribution of pharmaceutical products. The company offers over the counter (OTC) drugs, prescription drugs, energy drinks, insecticides and healthcare food items. Samsung Pharmaceutical Co.,Ltd. product portfolio includes gastrointestinal drugs, cough and cold syrup, eye solutions, analgesics, anti-inflammatory drugs, multivitamins, cardiovascular drugs, antihistamines, antacids, antidiarrhea, cholesterol reducing products, anti-obesity products, among others. The company is based in Hwaseong, Gyeonggi-do Province, South Korea. Samsung Pharmaceutical Co.,Ltd. was incorporated in 1929 formerly known as Samsung Pharmaceutical Industry Co., Ltd.

Headquarters
35 Jeyakgongdan 2-Gil, Hyangnam-Eup
Hwaseong; Gyeonggi; Postal Code: 18622

Contact Details: Purchase the Samsung Pharmaceutical Co.,Ltd. report to view the information.

Website: http://www.sspharm.co.kr

Basic Information
Total Employees:
Purchase the Samsung Pharmaceutical Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Samsung Pharmaceutical Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Samsung Pharmaceutical Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Samsung Pharmaceutical Co.,Ltd. report to view the information.
Incorporation Date:
August 15, 1929
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
23.07%
Purchase this report to view the information.
0.72%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.36%
Purchase this report to view the information.
0.17%
Subsidiaries
(주)젬백스링크
(주)젬백스앤카엘
(주)젬백스지오
Company Performance
Financial values in the chart are available after Samsung Pharmaceutical Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
0.24%
Total operating revenue
-4.9%
Operating profit (EBIT)
6.84%
EBITDA
-15.52%
Net Profit (Loss) for the Period
1.12%
Total assets
-20.72%
Total equity
-24.37%
Operating Profit Margin (ROS)
3.56%
Net Profit Margin
0.65%
Return on Equity (ROE)
-7.52%
Debt to Equity Ratio
-1.18%
Quick Ratio
-3.51%
Cash Ratio
-2.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?